Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells

Journal of Experimental Medicine

Volumn 187, Issue 6, 1998, Pages 897-902

  De Maria, Ruggero ^a   Rippo, Maria Rita ^a   Schuchman, Edward H ^b   Testi, Roberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GANGLIOSIDE GD3; MANNOSE RECEPTOR; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; HYDROLYSIS; NIEMANN PICK DISEASE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CHO CELLS; CRICETINAE; GANGLIOSIDES; HUMANS; LYMPHOCYTES; MICE; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 0032536876     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.6.897     Document Type: Article

References (22)

1. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science. 267:1449-1456.
2. Krammer, P.H. 1996. The CD95(APO-1/Fas) receptor/ligand system: death signals and disease. Cell Death and Differentiation. 3:159-160.
3. Muzio, M., A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J.N. Carsten-Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, M. Mann, et al. 1996. FLICE, a novel FADD homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/Apo-1) death-inducing signaling complex. Cell. 85:817-827.
4. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:803-815.
5. Los, M., M. Van de Craen, L.C. Penning, H. Schenk, M. Westendorp, P.A. Bauerle, W. Dröge, P.H. Krammer, W. Fiers, and K. Schulze-Osthoff. 1995. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature. 375:81-83.
6. Enari, M., H. Hug, and S. Nagata. 1995. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature. 375:78-81.
7. Testi, R. 1996. Sphingomyelin breakdown and cell fate. Trends Biochem. Sci. 21:468-471.
8. Cifone, M.G., R. De Maria, P. Roncaioli, M.R. Rippo, M. Azuma, L.L. Lanier, A. Santoni, and R. Testi. 1994. Apoptotic signaling through CD96 (Fas/APO-1) activates an acidic sphingomyelinase. J. Exp. Med. 180:1547-1552.
9. Gulbins, E., R. Bissonette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, G. Byrd, F. Lang, et al. 1995. Fas-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity. 2: 341-351.
10. Cifone, M.G., P. Roncaioli, R. De Maria, G. Camarda, A. Santoni, G. Ruberti, and R. Testi. 1995. Multiple signaling originate at the Fas/Apo-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. EMBO (Eur. Mol. Biol. Organ.) J. 14:5859-5868.
11. De Maria, R., M.L. Lenti, F. Malisan, F. d'Agostino, B. Tomassini, A. Zeuner, M.R. Rippo, and R. Testi. 1997. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 277:1652-1655.
12. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for cytochrome c. Cell. 86:147-157.
13. Susin, S.A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1341.
14. Kroemer, G., N. Zamzami, and S.A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today. 18:44-51.
15. Tepper, C.G., S. Jayadev, B. Liu, A. Bielawska, R. Wolff, S. Yonehara, Y.A. Hannun, and M. Seldin. 1995. Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA. 92:8443-8447.
16. Hannun, Y.A. 1996. Functions of ceramide in coordinating cellular responses to stress. Science. 274:1855-1859.
17. Kolesnick, R., and Z. Fuks. 1995. Ceramide: a signal for apoptosis or mitogenesis? J. Exp. Med. 181:1949-1952.
18. Schuchman, E.H., M. Suchi, T. Takahashi, K. Sandhoff, and R. Desnick. 1991. Human acidic sphingomyelinase. Isolation, nucleotide sequence and expression of the full length and alternatively spliced cDNA. J. Biol. Chem. 266:8531-8539.
19. Santana, P., L. Peña, A. Haimovitz-Friedman, S. Martin, D. Green, M. McLaughlin, C. Cordon-Cardo, E.H. Schuchman, Z. Fuks, and R. Kolesnick. 1996. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:189-199.
20. 2+-stimulated sphingomyelinase is secreted by many cell types and is the product of the acidic sphingomyelinase gene. J. Biol. Chem. 271:18431-18436.
21. Wiegmann, K., S. Schütze, T. Machleidt, D. Witte, and M. Krönke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1005-1015.
22. De Maria, R., M. Boirivant, M.G. Cifone, V. Roncaioli, M. Hahne, J. Tschopp, F. Pallone, A. Santoni, and R. Testi. 1996. Functional expression of Fas and Fas ligand on human gut lamina propria lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation. J. Clin. Invest. 97:316-322.